Gisèle N'kontchou

Summary

Country: France

Publications

  1. doi request reprint Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients
    Gisele Nkontchou
    Liver Unit Jean Verdier Hospital, UPRES EA 3409, UFR SMBH, Universite Paris 13, France
    Eur J Gastroenterol Hepatol 25:94-8. 2013
  2. pmc A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
    Tim F Greten
    Department of Gastroenterology, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    BMC Cancer 10:209. 2010
  3. doi request reprint Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis
    Gisele Nkontchou
    Department of Hepatogastroenterology, Hopital Jean Verdier, Bondy, France
    J Hepatol 53:827-33. 2010
  4. doi request reprint Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis
    Pierre Nahon
    Service d Hepatologie, Hopital Jean Verdier, AP HP, Bondy, France
    Hepatology 50:1484-93. 2009
  5. doi request reprint A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis
    Pierre Nahon
    Service d Hepatologie, Hopital Jean Verdier, AP HP, Bondy, France
    J Hepatol 56:426-32. 2012
  6. ncbi request reprint Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost
    Olivier Seror
    Service de Radiologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, Bondy
    Gastroenterol Clin Biol 30:1265-73. 2006
  7. doi request reprint Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis
    Gisèle N'kontchou
    Department of Hepatogastroenterology, Hôpital Jean Verdier Assistance Publique Hôpitaux de Paris, Bondy, France
    Hepatology 50:1475-83. 2009
  8. doi request reprint Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis
    Olivier Seror
    Department of Radiology, Hopital Jean Verdier, Assistance Publique Hôpitaux de Paris Centre Hospitalier Universitaire Paris XIII, Bondy, France
    J Vasc Interv Radiol 19:718-24. 2008
  9. doi request reprint Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis
    Gisèle N'kontchou
    Department of Hepatogastroenterology, Hôpital Jean Verdier Assistance Publique Hôpitaux de Paris, Bondy, France
    J Hepatol 56:160-6. 2012
  10. pmc Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease
    Jean Claude Trinchet
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, 93143 Bondy Cedex, France
    World J Gastroenterol 13:2455-60. 2007

Collaborators

Detail Information

Publications20

  1. doi request reprint Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients
    Gisele Nkontchou
    Liver Unit Jean Verdier Hospital, UPRES EA 3409, UFR SMBH, Universite Paris 13, France
    Eur J Gastroenterol Hepatol 25:94-8. 2013
    ..Histopathologic changes in the non-neoplastic liver in this context are not well characterized...
  2. pmc A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
    Tim F Greten
    Department of Gastroenterology, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    BMC Cancer 10:209. 2010
    ..In this open label, single arm clinical trial, we analyzed the effect of a low dose cyclophosphamide treatment in combination with a telomerase peptide (GV1001) vaccination in patients with advanced HCC...
  3. doi request reprint Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis
    Gisele Nkontchou
    Department of Hepatogastroenterology, Hopital Jean Verdier, Bondy, France
    J Hepatol 53:827-33. 2010
    ..Mechanisms linking obesity and unfavourable outcomes in patients with viral hepatitis C (HCV) cirrhosis are not well understood. Obesity is associated with insulin resistance, increased leptin, and decreased adiponectin serum levels...
  4. doi request reprint Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis
    Pierre Nahon
    Service d Hepatologie, Hopital Jean Verdier, AP HP, Bondy, France
    Hepatology 50:1484-93. 2009
    ..4% in patients with both the GG-MPO genotype and one or two Ala-SOD2 alleles, 5.1% in patients with only one of these two traits, and 0% in patients with none of these traits. Corresponding 5-year death rates were 37.6%, 11.6%, and 5%...
  5. doi request reprint A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis
    Pierre Nahon
    Service d Hepatologie, Hopital Jean Verdier, AP HP, Bondy, France
    J Hepatol 56:426-32. 2012
    ..We assessed the role of the G(-463)A-MPO, T(-262)C-CAT, Ala16Val-SOD2, and Pro198Leu-GPx1 variants in modulating HCC development in patients with HCV-induced cirrhosis...
  6. ncbi request reprint Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost
    Olivier Seror
    Service de Radiologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, Bondy
    Gastroenterol Clin Biol 30:1265-73. 2006
    ..To compare cost effectiveness of radio-frequency (RF) ablation versus percutaneous ethanol (Pe) ablation for treatment of small hepatocellular carcinoma...
  7. doi request reprint Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis
    Gisèle N'kontchou
    Department of Hepatogastroenterology, Hôpital Jean Verdier Assistance Publique Hôpitaux de Paris, Bondy, France
    Hepatology 50:1475-83. 2009
    ..34; 1.52-3.6; P = 0.0001) and serum AFP levels (HR = 1.015, 1.014-1.016; P = 0.015). Tumor size was associated with local recurrence but not with overall and tumor-free survival...
  8. doi request reprint Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis
    Olivier Seror
    Department of Radiology, Hopital Jean Verdier, Assistance Publique Hôpitaux de Paris Centre Hospitalier Universitaire Paris XIII, Bondy, France
    J Vasc Interv Radiol 19:718-24. 2008
    ..To compare the results of radiofrequency (RF) ablation with internally cooled electrodes (ICEs) versus perfused electrodes (PEs) in patients with cirrhosis with small (<or=3 cm) hepatocellular carcinoma ineligible for resection...
  9. doi request reprint Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis
    Gisèle N'kontchou
    Department of Hepatogastroenterology, Hôpital Jean Verdier Assistance Publique Hôpitaux de Paris, Bondy, France
    J Hepatol 56:160-6. 2012
    ..However, the shortage of grafts, leads to attempt liver resection (LR) or radiofrequency ablation (RFA) as a first-line treatment for patients with Child-Pugh A cirrhosis...
  10. pmc Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease
    Jean Claude Trinchet
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, 93143 Bondy Cedex, France
    World J Gastroenterol 13:2455-60. 2007
    ..It is strongly suggested that antiviral treatment of HCV infection could prevent HCC occurrence, even in cirrhotic patients, mainly when a sustained virological response is obtained...
  11. ncbi request reprint Radiofrequency ablation for the treatment of liver tumors in the caudate lobe
    Olivier Seror
    Department of Radiology, Centre Hospitalier Universitaire Jean Verdier and UPRES EA 3409, UFR SMBH, Paris XIII, France
    J Vasc Interv Radiol 16:981-90. 2005
    ..To evaluate the effectiveness of radiofrequency (RF) ablation for liver tumors located in the caudate lobe...
  12. ncbi request reprint [Synopsis: Diagnosis and treatment of hepatocellular carcinoma in patients with cirrhosis]
    Nathalie Ganne-Carrie
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, AP HP et UFR SMBH, Universite Paris 13, 93143 Bondy Cedex, France
    Gastroenterol Clin Biol 26:73-7. 2002
  13. ncbi request reprint Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis
    Gisèle N'kontchou
    Department of Hepatogastroenterology, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, UPRES EA 3409, UFR SMBH, Universite Paris 13, Bondy, France
    Clin Gastroenterol Hepatol 4:1062-8. 2006
    ..The aim of this study was to show the predictive value of these factors in a cohort of 771 patients with well-compensated alcohol- or hepatitis C (HCV)-related cirrhosis who were screened prospectively for HCC...
  14. ncbi request reprint Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death
    Pierre Nahon
    Service d Hepatologie, Hopital Jean Verdier, AP HP, Bondy, France
    Clin Gastroenterol Hepatol 3:292-8. 2005
    ....
  15. doi request reprint Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis
    Jean Charles Nault
    Service d Hepatologie, Hopital Jean Verdier, AP HP, Bondy, France
    Cancer Epidemiol Biomarkers Prev 22:1343-52. 2013
    ..Proteoglycans are involved in neoangiogenesis and transduction of oncogenic signals, two hallmarks of carcinogenesis...
  16. doi request reprint Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities
    Jean Claude Trinchet
    AP HP, Hopital Jean Verdier, Service d Hepato Gastroenterologie, Bondy, F 93140, France
    Hepatology 54:1987-97. 2011
    ..002). No difference in either HCC incidence (P = 0.13) or in prevalence of tumors ≤30 mm in diameter (79% versus 70%, P = 0.30) was observed between the randomized groups...
  17. ncbi request reprint Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices
    Farhad Kazemi
    Hepatology Department, Hopital Jean Verdier, APHP, Universite Paris 13, Bondy, France
    J Hepatol 45:230-5. 2006
    ..Periodic endoscopic screening for oesophageal varices is recommended in patients with cirrhosis, but might be limited to a subgroup of patients if a simple non-invasive test was available to select those at risk of bleeding...
  18. ncbi request reprint Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients
    Gisèle N'kontchou
    Department of Hepato Gastroenterology, Hopital Jean Verdier, Bondy Cedex, France
    Eur J Gastroenterol Hepatol 17:179-84. 2005
    ..We provide a retrospective review of results and the tolerance of all PSE procedures in patients with cirrhosis in our department...
  19. ncbi request reprint Local/regional and systemic treatments of hepatocellular carcinoma
    Michel Beaugrand
    Liver Unit, Hopital Jean Verdier, 93143 Bondy, France
    Semin Liver Dis 25:201-11. 2005
    ....
  20. doi request reprint ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
    Marianne Ziol
    Service d Anatomie Pathologique, Groupe hospitalier Paris Seine Saint Denis, Hopital Jean Verdier, AP HP, 93143 Bondy, France Université Paris 13, Sorbonne Paris Cité, UFR SMBH, F 93000 Bobigny, France
    J Hepatol 59:1264-70. 2013
    ..So far, no tissue biomarker of recurrence has been validated in biopsy samples. We aimed at investigating the prognostic value of tissue biomarkers in HCC biopsy samples of patients treated with RFA...